These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3074732)

  • 1. A new method to test genetic models in HLA associated diseases: the MASC method.
    Clerget-Darpoux F; Babron MC; Prum B; Lathrop GM; Deschamps I; Hors J
    Ann Hum Genet; 1988 Jul; 52(3):247-58. PubMed ID: 3074732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing genetic models for IDDM by the MASC method.
    Clerget-Darpoux F; Babron MC
    Genet Epidemiol; 1989; 6(1):59-64. PubMed ID: 2499505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive effect of two candidate genes in a disease: extension of the marker-association-segregation chi(2) method.
    Dizier MH; Babron MC; Clerget-Darpoux F
    Am J Hum Genet; 1994 Nov; 55(5):1042-9. PubMed ID: 7977341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segregation analysis of two genetic markers in IDDM families under two-locus models.
    Dizier MH; Clerget-Darpoux F; Hochez J
    Genet Epidemiol; 1989; 6(1):71-5. PubMed ID: 2567261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The affected sib method. IV. Sib trios.
    Payami H; Thomson G; Motro U; Louis EJ; Hudes E
    Ann Hum Genet; 1985 Oct; 49(4):303-14. PubMed ID: 3865624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementation and maternal effect in insulin-dependent diabetes.
    Clerget-Darpoux F; Babron MC; Deschamps I; Hors J
    Am J Hum Genet; 1991 Jul; 49(1):42-8. PubMed ID: 2063876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-disease-locus model: segregation analysis using information on two markers in nuclear families. Application to IDDM.
    Dizier MH; Clerget-Darpoux F; Hochez J
    Tissue Antigens; 1990 Jul; 36(1):1-7. PubMed ID: 2247883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of genetic interrelationship among HLA-associated diseases.
    Payami H; Khan MH; Grennan DM; Sanders PA; Dyer PA; Thomson G
    Am J Hum Genet; 1987 Sep; 41(3):331-49. PubMed ID: 3631074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the role of HLA-linked and unlinked determinants of disease.
    Risch N
    Am J Hum Genet; 1987 Jan; 40(1):1-14. PubMed ID: 3468804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene dosage and suceptibility to insulin-dependent diabetes.
    Spielman RS; Baker L; Zmijewski CM
    Ann Hum Genet; 1980 Oct; 44(2):135-50. PubMed ID: 6459051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetic susceptibility to insulin-dependent diabetes mellitus: combined segregation and linkage analysis.
    Green A; Svejgaard A; Platz P; Ryder LP; Jakobsen BK; Morton NE; MacLean CJ
    Genet Epidemiol; 1985; 2(1):1-15. PubMed ID: 3863777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential HLA haplotype sharing conditional on proband genotype is likely a necessary consequence of all three allele heterogeneity models: a rebuttal.
    Rotter JI; Vadheim CM
    Genet Epidemiol Suppl; 1986; 1():359-62. PubMed ID: 3569865
    [No Abstract]   [Full Text] [Related]  

  • 13. A test based on the exact probability distribution of the chi 2 statistic--incorporation into the MASC method.
    Müller B; Clerget-Darpoux F
    Ann Hum Genet; 1991 Jan; 55(1):69-75. PubMed ID: 2042937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical Bayes methods for testing associations with large numbers of candidate genes in the presence of environmental risk factors, with applications to HLA associations in IDDM.
    Thomas D; Langholz B; Clayton D; Pitkäniemi J; Tuomilehto-Wolf E; Tuomilehto J
    Ann Med; 1992 Oct; 24(5):387-92. PubMed ID: 1418924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic analysis of IDDM: summary of GAW5 IDDM results.
    Spielman RS; Baur MP; Clerget-Darpoux F
    Genet Epidemiol; 1989; 6(1):43-58. PubMed ID: 2659430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1.
    Valdes AM; Noble JA; Génin E; Clerget-Darpoux F; Erlich HA; Thomson G
    Genet Epidemiol; 2001 Nov; 21(3):212-23. PubMed ID: 11668578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of reduced fertility, method of ascertainment, and a second unlinked locus on affected sib-pair marker allele sharing.
    Risch N
    Am J Med Genet; 1983 Oct; 16(2):243-59. PubMed ID: 6580817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA and IDDM: facts and speculations on the disease gene and its mode of inheritance.
    Rubinstein P
    Hum Immunol; 1991 Apr; 30(4):270-7. PubMed ID: 2045289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classical HLA alleles tag SNP in families from Antioquia with type 1 diabetes mellitus.
    Sarrazola DC; Rodríguez AM; Toro M; Vélez A; García-Ramírez J; Lopera MV; Álvarez CM; González VB; Alfaro JM; Pineda-Trujillo N
    Biomedica; 2018 Sep; 38(3):329-337. PubMed ID: 30335238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
    Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
    Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.